HERON THERAPEUTICS, INC. /DE/ Non Peo Neo Avg Total Comp Amt
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Non Peo Neo Avg Total Comp Amt of $2.54 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-30
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.54M DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $1.48M DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $1.62M DEF 14A · filed 2026-04-30 |
| 2022-12-31 | $1.44M DEF 14A · filed 2026-04-30 |
| 2021-12-31 | $1.58M DEF 14A · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |